In some hospitals, albumin products account for 10% of the pharmaceutical budget.4 As much as 60% of these prescriptions are empiric, and from 40 to 70% of albumin that is administered is given for inappropriate reasons.4-6,14,15 Although the reasons for albumin administration vary, prevention or reversal of hypovolemia is part of the reason in the majority of cases. (Journal of Parenteral and Enteral Nutrition 15:484-487, 1991)
Get full access to this article
View all access options for this article.
References
1.
Tullis J.: Albumin II: Guidelines for clinical use. JAMA237:460, 1977
2.
Fell GS, Majaraj D.: Trace metal contamination of albumin solutions used for plasma exchange . Lancet2:467-468, 1986
3.
Medical Knowledge Self Assessment Program. 8th ed. Occupational Medicine. American College of Physicians , Philadelphia, 1988.
4.
Alexander MR , Spector R.: Rational use of albumin: Drug Therapy Review . J Iowa Med Soc70:111-113, 1980
5.
Alexander MR : Therapeutic use of albumin 1. JAMA241(23):2527-2529, 1979
6.
Alexander MR : Therapeutic use of albumin 2. JAMA247(6):831-833, 1979
7.
Starling F.: On the absorption of fluids from the connective tissue spaces. J Physiology19:312, 1896
8.
Druker CK, Filed ME: The protein content of mammalian lymph and the relation of lymph to tissue fluid. Am J Physiology97:32, 1931
9.
Shoemaker WC : Evaluation of colloids, crystalloids, whole blood, and red cell therapy in the critically ill patient. Clin Lab Med2(1):35-63, 1982
10.
Skillman JK , Parish RBN, Tanenbaum GJ: Pulmonary arteriovenous admixture: Improvement with albumin and diuresis. Am J Surg119:440-447, 1970
11.
Virgilio RW , Smith DE, Zarins CK, et al: Crystalloid vs colloid resuscitation: Is one better than the other? A randomized clinical study. Surg85(2):129-139, 1979
12.
Thompson JE , Vollman RW, Austin DJ, et al: Prevention of hypotensive and renal complications of aortic surgery using balanced salt solution: 13 year experience with 670 cases. Ann Surg167(5):767-778, 1974
13.
Sibbald WW, Driedger AA, Wells, GA et al: The short-term effect of increasing plasma colloid osmotic pressure in patients with noncardiac pulmonary edema. Surg93(5):620-623, 1983
14.
Tullis JL: Albumin 1: Background and use. JAMA237(4):355-359, 1977
15.
Klapp D., Harrison W.: Evaluation of albumin use by medical audit. Am J Hosp Pharm36:1205-1209, 1979
16.
Smith PC, Frank HA, Skillman JJ: Albumin deposition in human lung, skin, and skeletal muscle during surgery . Surg Forum91-93, 1975
17.
Schloerb RP , Hunt PT, Cage K., et al: Pulmonary edema after replacement of blood loss by electrolyte solutions. Surg Gynecol Obstet135:893-896, 1972
18.
Dawidson D. , Ottoson J., Reisch JS: Infusion volumes of Ringer's lactate and 3% albumin solution as they relate to survival after resuscitation of a lethal intestinal ischemic shock. Circ Shock19:277-288, 1986
19.
Dawidson I. , Gelin LE, Haglind E.: Plasma volume, intravascular protein content, hemodynamic and oxygen transport changes during intestinal shock in dogs. Crit Care Med8(2):73-80, 1980
20.
Albumin Structure Function and Uses. Rosenoer, Oratz, Rothschild (eds). New York, Elmsford, Pergamon Press, 1977
21.
Weaver DW, Ledgerwood AM, Lucas CE, et al: Pulmonary effects of albumin resuscitation for severe hypovolemic shock. Arch Surg113:387-392, 1978
22.
Hoye RC, Bennett SH, Heelhoed GW, et al: Fluid volume and albumin kinetics occurring with major surgery . JAMA222(10):1255-1261, 1972
23.
Shires GT, Canizaro PC: Fluid resuscitation in the severely injured. Surg Clin North Am53(6):1341-1366, 1973
24.
Rothschild MA, Oratz M., Schreiber S.: Albumin metabolism . Gastroenterology64:324-337, 1973
25.
Granger DN, Galel JC, Drake RE, et al: Physiologic basis for the clinical use of albumin solutions : Surg Gynecol Obstet146:97-104, 1978
26.
Henrikson JH , Parving HK, Lssen HA, et al: Increased transvascular escape rate and lymph drainage of albumin in pigs during intravenous diuretic medication . Scand J Clin Lab Invest42:423-429, 1982
27.
Collins JA, Braitberg A., Butcher HR: Changes in lung and body weight and lung water content in rats treated for hemorrhage with various fluids. Surg73(3):401-411, 1973
28.
Shine KI, Kuhn M., Young LS, et al: Aspects of the management of shock. Ann Intern Med93:723-734, 1980
29.
Zarins CK, Rice CL, Peters RM, et al: Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons. Circ Res43(6):925-930, 1978
30.
Gaisford WD , Pandey N., Jensen CG: Pulmonary changes in treated hemorrhagic shock II. Ringer's lactate solution vs colloid infusion . Am J Surg124(6):738-743, 1972
31.
Lowe RJ, Moss GS, Hilek J., et al: Crystalloid vs colloid in the etiology of pulmonary failure after trauma-A randomized trial in man. Crit Care Med (3):107-112, 1979
32.
Skillman JJ , Restall DS, Salzman EW: Randomized trial of albumin vs electrolyte solutions during abdominal aortic operations. Surgery78(3):291-293, 1975
33.
Marty AT: Hyperoncotic albumin therapy. Surg Gynecol Obstet139:105-109, 1974
34.
Harrison's Internal Medicine: Braunwald E, Isselbacher KJ, Wilson JD, et al (eds). McGraw Hill Book Company, New York, 1987, p. 1349
35.
Moss GS, Siegel DC, Cochin A., et al: Effects of saline and colloid solutions on pulmonary function in hemorrhagic shock. Surg Gynecol Obstet13:53-58, 1971
36.
Abel FL, Wolf MB: Increased capillary permeability to 125 I-labelled albumin during experimental hemorrhagic shock. Trans NY Acad Sci35:243-252, 1973
37.
Holcroft JW , Trunkey DD: Extravascular lung water following hemorrhagic shock in the baboon. Ann Surg180(4):408-417, 1974
38.
Holcroft JW , Trunkey DD: Pulmonary extravasation of albumin during and after hemorrhagic shock in baboons. J Surg Res18:91-97, 1975
39.
Dawidson I. , Gelin LE, Hedman L., et al: Hemodilution and recovery from experimental intestinal shock in rats. Crit Care Med9:42-46, 1981
40.
Moss GS, Gupta TKD, Newson B., et al: The effect of saline solution resuscitation on pulmonary sodium and water distribution. Surg Gynecol Obstet136:934-940, 1973
41.
Guhac I., Rector WAG: Kinetics of albumin in cirrhosis. (Letter and Reply). J Lab Clin Med107(5):517-518, 1986
42.
Jelenko C., Williams JB, Wheller ML, et al: Studies in shock and resuscitation, I: Use of a hypertonic albumin-containing, fluid-demand regimen (HALFD) in resuscitation. Crit Care Med7(4):157-167, 1979
43.
Siegel DC, Cochin A., Geocaris T., et al: Effects of saline and colloid resuscitation on renal function . Ann Surg177:51-57, 1973
44.
Kohler JP, Rice CL, Moss GS: Albumin therapy in permeability pulmonary edema. J Surg Res33:482-487, 1982
45.
Dawidson I. , Eriksson B., Gelin LE, et al: Oxygen consumption and recovery from surgical shock in rats: A comparison of the efficacy of different plasma substitutes . Crit Care Med7(10):460-465, 1979
46.
Buscaglia AJ , Tullis JL: Starling's law and albumin therapy (Letter and Reply). JAMA238(9):963, 1977
47.
Moss GS, Lowe RJ, Jilek J., et al: Colloid or crystalloid in the resuscitation of hemorrhagic shock: A controlled clinical trial. Surg89(4):434-438, 1981
48.
Dahn MS, Lucas C., Ledgewood, et al: Negative inotrophic effect of albumin resuscitation for shock. Surg86:235-241, 1989
49.
Weil MA, Hemming RJ, Pueri VK: Colloid oncotic pressure: Clinical significance. Crit Care Med7(3):113-116, 1979
50.
Karanko MS, Laaksonen O., Meratoja OA: Effects of concentrated albumin treatment after aortocoronary bypass surgery . Crit Care Med15(8):727-742, 1987
51.
Lumb PH: A comparison between 25% albumin and 6% hydroxyethyl starch solutions on lung water accumulation during and immediately after cardiopulmonary bypass . Ann Surg206(2):210-213, 1987
52.
Civetta JM: A new look at the Starling equation. Crit Care Med7(3):84-91, 1979
53.
Lucas CE, Weaver D., Higgins RP, et al: Effects of albumin versus non-albumin resuscitation on plasma volume and renal excretory function. J Trauma18(8):564-570, 1978
54.
Levy G.: Effect of plasma binding of drugs on duration and intensity of pharmacologic activity. J Pharmacol Sci65(8):1264-1265, 1976
55.
Rackowec ED, Falk JL, Fein LA, et al: Fluid-resuscitation in circulatory shock: A comparison of the cardiorespiratory effects of albumin, hetastarch and saline solution in patients with hypovolemic and septic shock. Crit Care Med11(11):839-850, 1983
56.
Baudendistel L., Dahms TE, Kaminski DL, et al: The effect of albumin on extravascular lung water in animals and patients with low-pressure pulmonary edema. J of Surg Res33:285-293, 1982
57.
Alving BM, Hojima Y.Pisano JJ, et al: Hypotension associated with prekallekrein activator (Hageman factor fragments in plasma protein fractions. N Engl J Med66:299, 1978
58.
Demling RH: Burns. N Engl J Med313:1389, 1985
59.
Moss GS, Gould SA: Plasma expanders: An update. Am J Surg155:425, 1988
60.
Hauser CJ, Shoemaker WC, Turpin I., et al: Oxygen transport responses to colloids and crystalloids in critically ill surgical patients. Surg Gynecol Obstet150:811, 1980
61.
Shine KI, Kuhn M., Young LS, et al: Aspects of the management of shock. Ann Intern Med93:723, 1980
